A: The maximum amount of product available via this program is two vials.
CSL supports Material Transfer (MT) of post-approval product in limited quantity via the Material Transfer Agreement (MTA). MT requests must undergo a thorough internal review process to ensure the protection of the intellectual property of CSL.
To request a Material Transfer, an external investigator must be a licensed healthcare provider or a researcher at a licensed laboratory or government agency (eg, NIH, FDA, etc.).